SNST (Aphex BioCleanse Systems) Market Cap: $0.27 Mil (As of Jun. 25, 2026)


What is Aphex BioCleanse Systems Market Cap?

Aphex BioCleanse Systems SNST Market Cap is $0.27 Mil as of Jun. 25, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aphex BioCleanse Systems's share price for the quarter that ended in . 20 was $. Aphex BioCleanse Systems's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Aphex BioCleanse Systems's market cap for the quarter that ended in . 20 was $ Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aphex BioCleanse Systems's Enterprise Value for Today is $0.03 Mil.

Aphex BioCleanse Systems  (OTCPK:SNST) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Aphex BioCleanse Systems Market Cap Related Terms

Aphex BioCleanse Systems Market Cap Historical Data

* Premium members only.

The historical data trend for Aphex BioCleanse Systems's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aphex BioCleanse Systems Market Cap Chart

Aphex BioCleanse Systems Annual Data
Trend
Market Cap

Aphex BioCleanse Systems Quarterly Data
Market Cap

Aphex BioCleanse Systems Market Cap Competitor Comparison

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aphex BioCleanse Systems Market Cap vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Market Cap distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's Market Cap falls into.


Aphex BioCleanse Systems Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Aphex BioCleanse Systems's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )=Share Price (A: . 20 )*Shares Outstanding (EOP) (A: . 20 )
=$*
=$

Aphex BioCleanse Systems's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )=Share Price (Q: . 20 )*Shares Outstanding (EOP) (Q: . 20 )
=$*0
=$

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.27 Mil mean?
Aphex BioCleanse Systems (SNST) has a Market Cap of $0.27 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' Market Cap too high?
Aphex BioCleanse Systems' current Market Cap is $0.27 Mil. The Consumer Packaged Goods industry median Market Cap is 101.90. Aphex BioCleanse Systems' value of $0.27 Mil is 99.7% below this industry median.
How does Aphex BioCleanse Systems' Market Cap compare to competitors?
Aphex BioCleanse Systems' Market Cap of $0.27 Mil can be compared against companies in the Consumer Packaged Goods industry. The industry median Market Cap is 101.90. Aphex BioCleanse Systems' value of $0.27 Mil is 99.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 101.90, based on 2,041 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aphex BioCleanse Systems's current Market Cap of $0.27 Mil is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aphex BioCleanse Systems and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 101.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aphex BioCleanse Systems's current Market Cap is $0.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current Market Cap of $0.27 Mil. The current Market Cap is $0.27 Mil and 99.7% below the Consumer Packaged Goods industry median of 101.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current Market Cap is $0.27 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aphex BioCleanse Systems Business Description

Address 1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.